Astellas Pharma Inc. has successfully completed the acquisition of Propella Therapeutics, Inc., making Propella a wholly-owned subsidiary of Astellas as of December 21, 2023. The acquisition incl...
Introduction Alu-alu blister represents the new generation in pharmaceutical packaging. The Cold Form Alu Alu blisters produced at Pack Time are available with various printed patterns to give uniq...
Astellas Pharma Inc. and Propella Therapeutics, Inc. have entered into a merger agreement, marking a significant development in the field of digital wealth management. Through its U.S. subsidiary...
Singapore-based pharmaceutical company, Juniper Biologics, has been awarded the prestigious title of "Most Innovative Oncology Pharmaceutical Company 2023" by the Global Health & Pharma (GHP)...
Ascentage Pharma, a global biopharmaceutical company focused on developing innovative treatments for cancer, chronic hepatitis B (CHB), and age-related diseases, has announced a significant clini...
